Filing Details

Accession Number:
0000899243-18-029698
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-11-27 19:01:56
Reporting Period:
2018-08-01
Accepted Time:
2018-11-27 19:01:56
Original Submission Date:
2018-08-03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
319016 Fuse Medical Inc. FZMD Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 591224913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688081 Reeg Medical Industries, Inc. 3024 Westminster Avenue
Dallas TX 75205
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-01 2,539,474 $0.76 6,539,474 No 4 P Direct
Common Stock Acquisiton 2018-10-04 72,139 $0.68 6,611,613 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This Form 4/A amends the Form 4 filed by Reeg Medical Industries, Inc. ("RMI") on August 3, 2018, to correct the number of shares of common stock, par value $0.01 (the "Common Stock"), of the Fuse Medical, Inc., a Delaware corporation (the "Company"), that Reeg received pursuant to that certain Securities Purchase Agreement, dated July 30, 2018 (the "Maxim Purchase Agreement"), by and between the Company, Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company ("Maxim"), RMI, Mr. Amir David Tahernia, an individual ("Tahernia", together with RMI, the "Sellers"), and Tahernia in his capacity as the representative of the Sellers (the "Sellers Representative"). The Company made a calculation error when computing the number of shares of Common Stock issued to RMI, and corrected the number in its Current Report on Form 8-K/A filed with the Securities and Exchange Commission (the "SEC") on November 16, 2018 (the "Maxim Form 8-K/A").
  2. On October 4, 2018, the Company issued 72,139 shares of Common Stock to RMI, which represents RMI's pro rata share of the agreed-upon purchase price adjustment pursuant to Pursuant to the Maxim Purchase Agreement, as reported in the Maxim Form 8-K/A.